We are live on !
Find out more
Silverback Asset Management Portfolio holdings
AUM
$925M
Turnover
20.27%
1-Year Est. Return
74.97%
This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+74.97%
3 Year Est. Return
+92.15%
5 Year Est. Return
+87.42%
10 Year Est. Return
+103.26%
AUM
$925M
AUM Growth
+$226M
(+32%)
Cap. Flow
-$385M
Cap. Flow % of AUM
Cap. Flow %
-41.65%
Top 10 Holdings %
Top 10 Hldgs %
45.67%
Holding
74
New
5
Increased
2
Reduced
6
Closed
10
Avg Time Held
Equity + Options
0.6
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.3
years
Avg Time Held Equity only
0.6
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ocugen
OCGN
|
+$380K |
| 2 |
Vroom Inc
VRM
|
+$139K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Harmonic Inc
HLIT
|
+$1.58M |
| 2 |
NeoGenomics
NEO
|
+$1.23M |
| 3 |
Scorpio Tankers
STNG
|
+$747K |
| 4 |
Core Scientific
CORZ
|
+$690K |
| 5 |
Magnachip Semiconductor
MX
|
+$582K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 97.11% |
| 2 | Technology | 1.67% |
| 3 | Financials | 0.63% |
| 4 | Healthcare | 0.37% |
| 5 | Industrials | 0.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
CALL
iShares Russell 2000 ETF
IWM
$74.9B
| $82.6M | 8.93% |
275,000
+175,000
| +175% | +$49.2M |
2026 Q1
1 quarter
|
|
2
Oracle Corp Preferred Stock Series D
ORCL.PRD
| – | – |
0
| – | – |
2026 Q1
1 quarter
|
|
3
CALL
Definium Therapeutics
DFTX
$4.88B
| $13.8M | 1.5% |
294,400
| – | – |
2026 Q1
1 quarter
|
|
|
4
Harmonic Inc
HLIT
$1.12B
| $8.57M | 0.93% |
525,000
-123,566
| -19% | -$1.58M |
2025 Q2
4 quarters
|
|
5
CALL
Cytokinetics
CYTK
$8.76B
| $8.52M | 0.92% |
+100,000
| New | +$7.18M |
2026 Q2
0 quarters
|
|
6
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$48.6B
| $7.93M | 0.86% |
+50,000
| New | +$7.44M |
2026 Q2
0 quarters
|
|
7
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.8B
| $7.91M | 0.86% |
+50,000
| New | +$6.76M |
2026 Q2
0 quarters
|
|
8
CALL
Nutanix
NTNX
$18.2B
| $5.1M | 0.55% |
+100,000
| New | +$4.52M |
2026 Q2
0 quarters
|
|
|
9
Vroom Inc
VRM
$39M
| $3.46M | 0.37% |
449,236
+11,300
| +3% | +$139K |
2025 Q1
5 quarters
|
|
|
10
Core Scientific
CORZ
$4.26B
| $3.37M | 0.36% |
131,600
-29,300
| -18% | -$690K |
2025 Q4
2 quarters
|
|
11
PUT
Lucid Motors
LCID
$1.19B
| $3.14M | 0.34% |
470,000
| – | – |
2025 Q3
3 quarters
|
|
12
CALL
PAR Technology
PAR
$731M
| $2.61M | 0.28% |
150,000
| – | – |
2026 Q1
1 quarter
|
|
13
TeraWulf
WULF
$5.85B
| $2.39M | 0.26% |
96,600
| – | – |
2025 Q4
2 quarters
|
|
14
AST SpaceMobile
ASTS
$12.3B
| $2.15M | 0.23% |
24,200
| – | – |
2025 Q4
2 quarters
|
|
15
AeroVironment
AVAV
$6.41B
| $2M | 0.22% |
12,100
| – | – |
2025 Q4
2 quarters
|
|
16
Tempus AI
TEM
$13.2B
| $1.66M | 0.18% |
28,700
-7,000
| -20% | -$351K |
2025 Q4
2 quarters
|
|
17
CALL
EyePoint Inc
EYPT
$30M
| $1.43M | 0.15% |
100,000
| – | – |
2026 Q1
1 quarter
|
|
18
CALL
Karyopharm Therapeutics
KPTI
$15M
| $977K | 0.11% |
100,000
| – | – |
2026 Q1
1 quarter
|
|
19
DELISTED
LivePerson
LPSN
| $922K | 0.1% |
485,001
| – | – |
2025 Q4
2 quarters
|
|
|
20
EyePoint Inc
EYPT
$30M
| $715K | 0.08% |
50,000
| – | – |
2026 Q1
1 quarter
|
|
|
21
Magnachip Semiconductor
MX
$180M
| $473K | 0.05% |
100,000
-120,000
| -55% | -$582K |
2025 Q2
4 quarters
|
|
|
22
Ocugen
OCGN
$238M
| $382K | 0.04% |
+250,000
| New | +$380K |
2026 Q2
0 quarters
|
|
23
Accuray
ARAY
$16.7M
| $374K | 0.04% |
1,450,000
-200,000
| -12% | -$74.4K |
2025 Q2
4 quarters
|
|
|
24
Karyopharm Therapeutics
KPTI
$15M
| $293K | 0.03% |
30,000
-35,000
| -54% | -$304K |
2025 Q1
5 quarters
|
|
25
PUT
Invesco Senior Loan ETF
BKLN
$6.04B
| – | – |
-112,100
| Closed | -$2.29M | – |
|
Similar funds
MPM
Silverback Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Silverback Asset Management held 74 positions worth $925M, up 32% from $699M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Silverback Asset Management withdrew a net $385M in Q2 2026, closing 10 positions and reducing 6 holdings. Its most notable exit was NeoGenomics, an estimated $1.23M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 97% of assets, up from 96% a quarter earlier, followed by Technology and Financials.
Against the trend, Silverback Asset Management opened a new position in Ocugen worth $382K.
- Silverback Asset Management's largest Q2 2026 buy was Ocugen: 250,000 shares worth $382K.
- Silverback Asset Management added most to Vroom Inc in Q2 2026, an estimated $139K increase.
- Silverback Asset Management's biggest Q2 2026 reduction was Harmonic Inc, cutting an estimated $1.58M.
- Silverback Asset Management fully exited NeoGenomics in Q2 2026, selling an estimated $1.23M.
- Silverback Asset Management's ten largest holdings make up 46% of its $925M portfolio in Q2 2026.
- Silverback Asset Management opened 5 new positions and closed 10 in Q2 2026.
- Silverback Asset Management's portfolio value rose 32% quarter-over-quarter to $925M.
Based on Silverback Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.